NEWARK, Del, Dec. 13, 2022 (GLOBE NEWSWIRE) -- During the forecast period 2023-2033, the pharmaceutical dissolution testing services market is expected to grow at a value of 8.3% CAGR, according to Future Market Insights. By the year 2033, the global market for pharmaceutical dissolution testing services is expected to rise up to a market valuation of US$ 1,538.48 Million. The market is expected to increase primarily as a result of the rising drug development process, increasing technological advancements, rising awareness about the need for high-quality products, and the production of numerous medications for various chronic diseases that require dissolution testing.
For the physical assessment of solid dosage forms, such as tablets, capsules, ointments, and creams, dissolution testing is required. The simplest type of testing measures the solubility or rate of dissolving a medication tablet. Dissolution testing can be performed to assess the release rates of a drug material under various situations and to provide details regarding the effectiveness of in vivo performance in Absorption, Distribution, Metabolism, And Excretion (ADME) and bioavailability studies.
Request Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15959
Dissolution testing provides information on how quickly or slowly certain drugs are absorbed into various body parts and, subsequently, how much they dissolve after administration. This enables businesses to assess whether a drug will function effectively after it enters a patient's system and whether any negative effects brought on by slower absorption rates would occur.
Key Takeaways from the Market Study
- By dosage form, the tablets dosage form segment is expected to dominate the global industry in 2023 and account for the maximum share of more than 65% of the overall revenue.
- By dissolution apparatus, the paddle segment is expected to dominate the industry and account for the largest revenue share of more than 70% in 2023.
- By method, the in-vitro method segment is expected to dominate the global market in 2023 and account for the largest share of more than 58% of the overall revenue.
- North America is expected to dominate the global industry in 2023 and account for the maximum share of more than 50% of the overall revenue.
- Asia Pacific is expected to possess 33% market share for pharmaceutical dissolution testing services market in Asia Pacific.
“Pharmaceutical dissolution testing requires specialized staff to run the assays and prepare regulatory filings. This factor has greatly increased the demand for professional teams to handle pharmaceutical dissolution testing, which is predicted to have a favorable effect on the industry.” comments a Future Market Insights analyst.
Festive Offer! Get Customized Report at 30% Discount @ https://www.futuremarketinsights.com/checkout/15959
Competitive Landscape
Some of the prominent players in the global pharmaceutical dissolution testing services market include Intertek Group Plc, Avivia BV, Almac Group, Agilent Technologies, Inc, Catalent, Inc, Thermofisher Scientific Inc, Cambrex, Charles River Laboratories, Boston Analytical, Pace Analytical Life Sciences, SOTAX, AMRI, SGS SA
- In August 2022, Almac, AstraZeneca CDx have entered into a partnership that is branching out to new disease areas, drawing on NGS, qPCR. The company is focusing on investing in research and development to assess and understand nature of diseases and manufacture medication for the same.
- Avivia, a key player in pharmaceutical dissolution testing services market is focusing on offering full product development services to generic drug companies and specialty pharma focused on the development of new improved versions (value-added generics or generic plus) of established drug products.
Key Segments Profiled in the Pharmaceutical Dissolution Testing Services Industry Survey
By Method:
- In Vitro
- In Vivo
By Dosage Form:
- Capsules
- Tablets
- Others
By Dissolution Apparatus:
- Basket
- Paddle
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
More Valuable Insights
Future Market Insights, in its new offering, presents an unbiased analysis of the global pharmaceutical dissolution testing services market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023-2033.
Ask an Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15959
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
About the Healthcare at Future Market Insights
The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
Have a Look at Related Reports of Healthcare domain
Graft Versus Host Disease (GvHD) Treatment Market: The global graft versus host disease (GvHD) treatment market is expected to secure US$ 5,655.37 Million in 2032 while expanding at a CAGR of 8.3%.
Healthcare IT Outsourcing Market: The global healthcare IT outsourcing market is expected to reach a valuation of US$ 50,025.3 Million in 2022.
Hemostasis Testing Systems Market: The global hemostasis testing systems market is expected to secure US$ 3,518.1 Million in 2032 while expanding at a CAGR of 5.5%.
Implantable Infusion Pump Market: Implantable Infusion Pumps are projected to grow at a robust CAGR of 5.7% between 2022 and 2032, totaling around US$ 892.6 Million by the end of 2032.
Glioblastoma Treatment Drugs Market: The glioblastoma treatment drugs market is likely to secure a CAGR of 5.7% during the forecast period. The market is projected to be valued at US$ 723.30 million in 2022 and is expected to be valued at US$ 1,259.13 million by 2032.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, U.S., and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us
Future Market Insights Inc.
Christiana Corporate,
200 Continental Drive,
Suite 401, Newark,
Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
